You are here

UK - London

Stronger warnings are needed to curb socialising after vaccination--behaviorial scientists ,

Tue, 2021-03-23 15:40 — mike kraft

Covid-19: Stronger warnings are needed to curb socialising after vaccination, say doctors and behavioural scientists Experts have called for stronger health warnings for people being vaccinated against covid-19 after observing a rise in infections shortly after vaccination, suggesting that many people are letting their guard down before the vaccine has taken effect. Earlier this month a study led by Public Health England of vaccination in the over 70s found a “notable” rise in covid-19 infections in people immediately after they received the AstraZeneca vaccine.1 Similarly, a study of Israel’s vaccination programme, reported in February, found a similar spike in cases among people who had just been jabbed.2 It found that daily incidence approximately doubled after vaccination until about day 8.

Country / Region Tags:

General Topic Tags:

Public Attitudes

Social behavior

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Stronger warnings are needed to curb socialising after vaccination--behaviorial scientists ,
Log in or register to post comments

WHO says it will continue its rollout of AstraZenca vaccine, downplaying concerns

Tue, 2021-03-16 14:08 — mike kraft

WHO: Vaccine rollout unaffected by concerns over AstraZeneca The U.N. health agency says its global rollout of coronavirus vaccines remains unaffected even as a growing number of countries have suspended use of AstraZeneca’s vaccine amid concerns about blood clots in some people who received it Jamey Keaten | AP Washington Post

Country / Region Tags:

Democratic Republic of the Congo

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO says it will continue its rollout of AstraZenca vaccine, downplaying concerns
1 comment
Log in or register to post comments

Regular booster vaccines are the future to counter COVID-19 virus -- expert says

Mon, 2021-03-15 15:34 — mike kraft

Exclusive: Regular booster vaccines are the future in battle with COVID-19 virus, top genome expert says Regular booster vaccines against the novel coronavirus will be needed because of mutations that make it more transmissible and better able to evade human immunity, the head of Britain's effort to sequence the virus's genomes told Reuters. Guy Faulconbridge U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Read more about Regular booster vaccines are the future to counter COVID-19 virus -- expert says
Log in or register to post comments

Novavax vaccine showing high effectiveness against original coronavirus and British variant

Fri, 2021-03-12 01:22 — mike kraft

Novavax vaccine 96% effective against original coronavirus, 86% vs British variant in UK trial Novavax Inc's COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said on Thursday, moving it a step closer to regulatory approval. Dania Nadeem, Carl O’Donnell U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Novavax vaccine showing high effectiveness against original coronavirus and British variant
Log in or register to post comments

UK COVID-19 variant has significantly higher death rate--new study

Wed, 2021-03-10 14:38 — mike kraft

UK COVID-19 variant has significantly higher death rate, study finds A highly infectious variant of COVID-19 that has spread around the world since it was first discovered in Britain late last year is between 30% and 100% more deadly than previous dominant variants, researchers said on Wednesday. Kate Kelland U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK COVID-19 variant has significantly higher death rate--new study
Log in or register to post comments

study indicates AstraZeneca effective against Brazil variant, source says

Fri, 2021-03-05 17:18 — mike kraft

Exclusive: Oxford study indicates AstraZeneca effective against Brazil variant, source says Preliminary data from a study conducted at the University of Oxford indicates that the COVID-19 vaccine developed by AstraZeneca PLC is effective against the P1, or Brazilian, variant, a source with knowledge of the study told Reuters on Friday. Rodrigo Viga Gaier U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about study indicates AstraZeneca effective against Brazil variant, source says
Log in or register to post comments

New Study Shows One Dose of AstraZeneca Vaccine Protects Older People

Tue, 2021-03-02 01:39 — mike kraft

Covid vaccines cut risk of serious illness by 80% in over-80s The UK will soon be in a "very different world", government scientists promise after the success of the jabs. BBC News

A single shot of either the Oxford-AstraZeneca or the Pfizer-BioNTech Covid jab reduces the chance of needing hospital treatment by more than 80%, an analysis in England shows.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about New Study Shows One Dose of AstraZeneca Vaccine Protects Older People
Log in or register to post comments

UK sees sharp drop in Covid-19 cases following lockdown

Thu, 2021-02-25 18:06 — mike kraft

UK Covid-19 cases fall nearly 80% in 6 weeks of lockdown Covid-19 cases in England have fallen 78% since the government imposed a national lockdown on Jan. 4, according to weekly statistics from the National Health Service Test and Trace. By Eoin McSweeney, Hannah Strange and Jessie Yeung, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about UK sees sharp drop in Covid-19 cases following lockdown
Log in or register to post comments

AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official

Wed, 2021-02-24 00:49 — mike kraft

Exclusive: AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official AstraZeneca expects to deliver less than half the COVID-19 vaccines it was contracted to supply the European Union in the second quarter, an EU official told Reuters on Tuesday. Francesco Guarascio U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca to miss second-quarter EU vaccine supply target by half - EU official
Log in or register to post comments

British data study says COVID-19 vaccines sharply cut hospitalizations

Tue, 2021-02-23 00:11 — mike kraft

LONDON (AP) — Two U.K. studies released Monday showed that COVID-19 vaccination programs are contributing to a sharp drop in hospitalizations, boosting hopes that the shots will work as well in the real world as they have in carefully controlled studies.

Preliminary results from a study in Scotland found that the Pfizer-BioNTech vaccine reduced hospital admissions by up to 85% four weeks after the first dose, while the Oxford-AstraZeneca shot cut admissions by up to 94%. In England, preliminary data from a study of health care workers showed that the Pfizer vaccine reduced the risk of catching COVID-19 by 70% after one dose, a figure that rose to 85% after the second.

“This new evidence shows that the jab protects you, and protects those around you,” U.K. Health Secretary Matt Hancock said. “It is important that we see as much evidence as possible on the vaccine’s impact on protection and on transmission and we will continue to publish evidence as we gather it.’’

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about British data study says COVID-19 vaccines sharply cut hospitalizations
Log in or register to post comments

Pages

Page loaded in 0.629 seconds.